MedTrace Logo

A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases

NCT05188885 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90000

Last updated 2026-01-15

No results posted yet for this study

Summary

Chronic kidney disease (CKD) refers to a variety of different diseases characterized by impairment of kidney structure and/or renal function. The prevalence of CKD in China is as high as 10.8%. With a population of more than 150 million, China has the largest number of CKD patients all over the world. People with CKD would not only progress to uremia and need renal replace treatment, it also significantly increases risk of cardiovascular disease than non-CKD population. It has created a heavy burden on people's health and national economy. There is an urgent need to establish an effective system for CKD prevention and control in China. Evidences from large sample cohort and real world based research are still rare. This study will provide good experience for reducing the occurrence and development of CKD.

Conditions

Sponsors & Collaborators

  • Guangdong Provincial People's Hospital

    lead OTHER

Principal Investigators

  • Xueqing Yu, MD · Guangdong Provincial People's Hospital

  • Zhiming Ye, MD · Guangdong Provincial People's Hospital

  • Feng Wen, MD · Guangdong Provincial People's Hospital

  • Ting Lin, MD · Guangdong Provincial People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-27
Primary Completion
2026-12-27
Completion
2028-12-27

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05188885 on ClinicalTrials.gov